Literature DB >> 2420316

Earliest symptoms caused by neovascular membranes in the macula.

A M Fine, M J Elman, J E Ebert, P A Prestia, J S Starr, S L Fine.   

Abstract

One hundred three patients with neovascular maculopathy and relatively recent vision loss were surveyed to determine the most frequent symptoms and to assess the reliability of the Amsler grid in helping patients to detect early symptoms. Blurred vision and distortion, most often with near vision, were the most frequent first symptoms reported by patients. Of 49 patients who said that they were observing the Amsler grid on a regular basis, only five indicated that the Amsler grid abnormality was the first visual symptom. However, all but five of 49 patients did notice an Amsler grid abnormality during the office examination, suggesting noncompliance as the probable explanation for failure to detect an Amsler grid abnormality earlier. Patients at risk for neovascular maculopathy should be encouraged to assess a variety of visual functions--including reading vision, color saturation, and image clarity--in addition to observing the Amsler grid, in order to help them detect the earliest symptoms of submacular fluid from a potentially treatable neovascular membrane.

Entities:  

Mesh:

Year:  1986        PMID: 2420316     DOI: 10.1001/archopht.1986.01050160069013

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Face Fields and Microperimetry for Estimating the Location of Fixation in Eyes with Macular Disease.

Authors:  Janet S Sunness
Journal:  J Vis Impair Blind       Date:  2008-11

Review 2.  Neuro-Ophthalmological Emergencies.

Authors:  João Lemos; Eric Eggenberger
Journal:  Neurohospitalist       Date:  2015-10

Review 3.  The Amsler chart: absence of evidence is not evidence of absence.

Authors:  Michael Crossland; Gary Rubin
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

Review 4.  The prescription of assistive devices for the elderly: practical considerations.

Authors:  J H Wasson; V Gall; R McDonald; M H Liang
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

Review 5.  Symposium on age-related macular degeneration.

Authors:  L A Yannuzzi; R Friedman; S L Fine; J D Gass; K A Gitter; D H Orth; L J Singerman
Journal:  Bull N Y Acad Med       Date:  1988-12

Review 6.  Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis.

Authors:  L Faes; N S Bodmer; L M Bachmann; M A Thiel; M K Schmid
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

7.  A novel record for patients with neovascular age-related macular degeneration: providing information and a personal treatment record.

Authors:  M Shah; A M Haque; S M Downes
Journal:  Eye (Lond)       Date:  2017-11-17       Impact factor: 3.775

8.  Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1995-04-15       Impact factor: 8.262

9.  Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.

Authors:  Emily Y Chew; Traci E Clemons; Susan B Bressler; Michael J Elman; Ronald P Danis; Amitha Domalpally; Jeffrey S Heier; Judy E Kim; Richard Garfinkel
Journal:  Ophthalmology       Date:  2013-11-08       Impact factor: 12.079

Review 10.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.